Global Transdermal Gel Market

Transdermal Gel Comprehensive Study by Type (Ionophoresis, Electroporation, Sonophoresis), Application (Hospital, Clinic, Other), Distribution Channels (Ecommerce, Medical Stores, Hospital Pharmacies), End User (Adults, Adolescents, Children) Players and Region - Global Market Outlook to 2030

Transdermal Gel Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Transdermal Gel Market Scope
A transdermal gel is part of transdermal drug delivery which is the type of medication that is applied to and absorbed directly in the skin. The popularity of transdermal gel products is increasing as various drugs have been delivered by this route because of its non-invasive and painless treatment. The transdermal gels which are semi-solid systems consist of either suspension with small inorganic particles or large organic molecules mixed with liquid. The increasing number of skin disease cases and injuries are driving the market along with the demand for minimally invasive and painless treatment.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies Profiled3M Company (United States), Novartis International AG (Germany), Boehringer Ingelheim International GmbH (Germany), Merck & Co., Inc. (United States), Mylan N.V (United States), Mary's Medicinal (United States) and Zynerba Pharmaceuticals, Inc. (United States)
CAGR%


Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Transdermal Gel market throughout the predicted period.

3M Company (United States), Novartis International AG (Germany), Boehringer Ingelheim International GmbH (Germany), Merck & Co., Inc. (United States), Mylan N.V (United States), Mary's Medicinal (United States) and Zynerba Pharmaceuticals, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Tapemark (United States) and LTS Lohmann Therapie-Systeme AG (Germany).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Transdermal Gel market by Type , by Application (Hospital, Clinic and Other) and Region with country level break-up.

On the basis of geography, the market of Transdermal Gel has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In October 2020 , DermBiont, Inc., a clinical stage precision dermatology company targeting skin diseases at their root cause has expanded its pipeline and therapeutic modalities with the acquisition of SeylanMED, Inc.
In February 2020, Zynerba Pharmaceuticals, Inc. leader in pharmaceutically produced transdermal cannabidiol therapies for rare and near rare neuropsychiatric disorders. The company announced the issue of new US patent no. titled "treatment of autism and cannabidiol" directed to methods of treating autism spectrum disorder (ASD) by transdermally administering via gel or cream, a therapeutically effective amount of purified cannabidiol (CBD).


Influencing Trend:
The Introduction of CBD based Transdermal Gel and Online Availability of Transdermal Gel

Market Growth Drivers:
Increasing Skin Diseases in People Across the World and Demand for Minimally Invasive and Painless Approach for Treatment

Challenges:
High Cost Associated with Transdermal Gel

Restraints:
Allergy-Related Problems with Transdermal Gel Might Hinder the Market

Opportunities:
Surging Popularity of Transdermal Drug System will Boost the transdermal Gel Market and Growing CBD Market will Boost the Transdermal Gel Market

Key Target Audience
Transdermal Gel Manufacturers, Transdermal Gel International Traders, Transdermal Gel Distributors and Suppliers, Research and Development Institutes, Potential Investors, Hospitals, Regulatory Bodies, Upstream and Downstream Buyers and Others

Report Objectives / Segmentation Covered

By Type
  • Ionophoresis
  • Electroporation
  • Sonophoresis
By Application
  • Hospital
  • Clinic
  • Other
By Distribution Channels
  • Ecommerce
  • Medical Stores
  • Hospital Pharmacies

By End User
  • Adults
  • Adolescents
  • Children

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Skin Diseases in People Across the World
      • 3.2.2. Demand for Minimally Invasive and Painless Approach for Treatment
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated with Transdermal Gel
    • 3.4. Market Trends
      • 3.4.1. The Introduction of CBD based Transdermal Gel
      • 3.4.2. Online Availability of Transdermal Gel
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Transdermal Gel, by Type, Application, Distribution Channels, End User and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Transdermal Gel (Value)
      • 5.2.1. Global Transdermal Gel by: Type (Value)
        • 5.2.1.1. Ionophoresis
        • 5.2.1.2. Electroporation
        • 5.2.1.3. Sonophoresis
      • 5.2.2. Global Transdermal Gel by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinic
        • 5.2.2.3. Other
      • 5.2.3. Global Transdermal Gel by: Distribution Channels (Value)
        • 5.2.3.1. Ecommerce
        • 5.2.3.2. Medical Stores
        • 5.2.3.3. Hospital Pharmacies
      • 5.2.4. Global Transdermal Gel by: End User (Value)
        • 5.2.4.1. Adults
        • 5.2.4.2. Adolescents
        • 5.2.4.3. Children
      • 5.2.5. Global Transdermal Gel Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Transdermal Gel (Volume)
      • 5.3.1. Global Transdermal Gel by: Type (Volume)
        • 5.3.1.1. Ionophoresis
        • 5.3.1.2. Electroporation
        • 5.3.1.3. Sonophoresis
      • 5.3.2. Global Transdermal Gel by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Clinic
        • 5.3.2.3. Other
      • 5.3.3. Global Transdermal Gel by: Distribution Channels (Volume)
        • 5.3.3.1. Ecommerce
        • 5.3.3.2. Medical Stores
        • 5.3.3.3. Hospital Pharmacies
      • 5.3.4. Global Transdermal Gel by: End User (Volume)
        • 5.3.4.1. Adults
        • 5.3.4.2. Adolescents
        • 5.3.4.3. Children
      • 5.3.5. Global Transdermal Gel Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Transdermal Gel (Price)
      • 5.4.1. Global Transdermal Gel by: Type (Price)
  • 6. Transdermal Gel: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. 3M Company (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Novartis International AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Boehringer Ingelheim International GmbH (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merck & Co., Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Mylan N.V (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Mary's Medicinal (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Zynerba Pharmaceuticals, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Transdermal Gel Sale, by Type, Application, Distribution Channels, End User and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Transdermal Gel (Value)
      • 7.2.1. Global Transdermal Gel by: Type (Value)
        • 7.2.1.1. Ionophoresis
        • 7.2.1.2. Electroporation
        • 7.2.1.3. Sonophoresis
      • 7.2.2. Global Transdermal Gel by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinic
        • 7.2.2.3. Other
      • 7.2.3. Global Transdermal Gel by: Distribution Channels (Value)
        • 7.2.3.1. Ecommerce
        • 7.2.3.2. Medical Stores
        • 7.2.3.3. Hospital Pharmacies
      • 7.2.4. Global Transdermal Gel by: End User (Value)
        • 7.2.4.1. Adults
        • 7.2.4.2. Adolescents
        • 7.2.4.3. Children
      • 7.2.5. Global Transdermal Gel Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Transdermal Gel (Volume)
      • 7.3.1. Global Transdermal Gel by: Type (Volume)
        • 7.3.1.1. Ionophoresis
        • 7.3.1.2. Electroporation
        • 7.3.1.3. Sonophoresis
      • 7.3.2. Global Transdermal Gel by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Clinic
        • 7.3.2.3. Other
      • 7.3.3. Global Transdermal Gel by: Distribution Channels (Volume)
        • 7.3.3.1. Ecommerce
        • 7.3.3.2. Medical Stores
        • 7.3.3.3. Hospital Pharmacies
      • 7.3.4. Global Transdermal Gel by: End User (Volume)
        • 7.3.4.1. Adults
        • 7.3.4.2. Adolescents
        • 7.3.4.3. Children
      • 7.3.5. Global Transdermal Gel Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Transdermal Gel (Price)
      • 7.4.1. Global Transdermal Gel by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Transdermal Gel: by Type(USD Million)
  • Table 2. Transdermal Gel Ionophoresis , by Region USD Million (2018-2023)
  • Table 3. Transdermal Gel Electroporation , by Region USD Million (2018-2023)
  • Table 4. Transdermal Gel Sonophoresis , by Region USD Million (2018-2023)
  • Table 5. Transdermal Gel: by Application(USD Million)
  • Table 6. Transdermal Gel Hospital , by Region USD Million (2018-2023)
  • Table 7. Transdermal Gel Clinic , by Region USD Million (2018-2023)
  • Table 8. Transdermal Gel Other , by Region USD Million (2018-2023)
  • Table 9. Transdermal Gel: by Distribution Channels(USD Million)
  • Table 10. Transdermal Gel Ecommerce , by Region USD Million (2018-2023)
  • Table 11. Transdermal Gel Medical Stores , by Region USD Million (2018-2023)
  • Table 12. Transdermal Gel Hospital Pharmacies , by Region USD Million (2018-2023)
  • Table 13. Transdermal Gel: by End User(USD Million)
  • Table 14. Transdermal Gel Adults , by Region USD Million (2018-2023)
  • Table 15. Transdermal Gel Adolescents , by Region USD Million (2018-2023)
  • Table 16. Transdermal Gel Children , by Region USD Million (2018-2023)
  • Table 17. South America Transdermal Gel, by Country USD Million (2018-2023)
  • Table 18. South America Transdermal Gel, by Type USD Million (2018-2023)
  • Table 19. South America Transdermal Gel, by Application USD Million (2018-2023)
  • Table 20. South America Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 21. South America Transdermal Gel, by End User USD Million (2018-2023)
  • Table 22. Brazil Transdermal Gel, by Type USD Million (2018-2023)
  • Table 23. Brazil Transdermal Gel, by Application USD Million (2018-2023)
  • Table 24. Brazil Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 25. Brazil Transdermal Gel, by End User USD Million (2018-2023)
  • Table 26. Argentina Transdermal Gel, by Type USD Million (2018-2023)
  • Table 27. Argentina Transdermal Gel, by Application USD Million (2018-2023)
  • Table 28. Argentina Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 29. Argentina Transdermal Gel, by End User USD Million (2018-2023)
  • Table 30. Rest of South America Transdermal Gel, by Type USD Million (2018-2023)
  • Table 31. Rest of South America Transdermal Gel, by Application USD Million (2018-2023)
  • Table 32. Rest of South America Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 33. Rest of South America Transdermal Gel, by End User USD Million (2018-2023)
  • Table 34. Asia Pacific Transdermal Gel, by Country USD Million (2018-2023)
  • Table 35. Asia Pacific Transdermal Gel, by Type USD Million (2018-2023)
  • Table 36. Asia Pacific Transdermal Gel, by Application USD Million (2018-2023)
  • Table 37. Asia Pacific Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 38. Asia Pacific Transdermal Gel, by End User USD Million (2018-2023)
  • Table 39. China Transdermal Gel, by Type USD Million (2018-2023)
  • Table 40. China Transdermal Gel, by Application USD Million (2018-2023)
  • Table 41. China Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 42. China Transdermal Gel, by End User USD Million (2018-2023)
  • Table 43. Japan Transdermal Gel, by Type USD Million (2018-2023)
  • Table 44. Japan Transdermal Gel, by Application USD Million (2018-2023)
  • Table 45. Japan Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 46. Japan Transdermal Gel, by End User USD Million (2018-2023)
  • Table 47. India Transdermal Gel, by Type USD Million (2018-2023)
  • Table 48. India Transdermal Gel, by Application USD Million (2018-2023)
  • Table 49. India Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 50. India Transdermal Gel, by End User USD Million (2018-2023)
  • Table 51. South Korea Transdermal Gel, by Type USD Million (2018-2023)
  • Table 52. South Korea Transdermal Gel, by Application USD Million (2018-2023)
  • Table 53. South Korea Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 54. South Korea Transdermal Gel, by End User USD Million (2018-2023)
  • Table 55. Taiwan Transdermal Gel, by Type USD Million (2018-2023)
  • Table 56. Taiwan Transdermal Gel, by Application USD Million (2018-2023)
  • Table 57. Taiwan Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 58. Taiwan Transdermal Gel, by End User USD Million (2018-2023)
  • Table 59. Australia Transdermal Gel, by Type USD Million (2018-2023)
  • Table 60. Australia Transdermal Gel, by Application USD Million (2018-2023)
  • Table 61. Australia Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 62. Australia Transdermal Gel, by End User USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Transdermal Gel, by Type USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Transdermal Gel, by Application USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Transdermal Gel, by End User USD Million (2018-2023)
  • Table 67. Europe Transdermal Gel, by Country USD Million (2018-2023)
  • Table 68. Europe Transdermal Gel, by Type USD Million (2018-2023)
  • Table 69. Europe Transdermal Gel, by Application USD Million (2018-2023)
  • Table 70. Europe Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 71. Europe Transdermal Gel, by End User USD Million (2018-2023)
  • Table 72. Germany Transdermal Gel, by Type USD Million (2018-2023)
  • Table 73. Germany Transdermal Gel, by Application USD Million (2018-2023)
  • Table 74. Germany Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 75. Germany Transdermal Gel, by End User USD Million (2018-2023)
  • Table 76. France Transdermal Gel, by Type USD Million (2018-2023)
  • Table 77. France Transdermal Gel, by Application USD Million (2018-2023)
  • Table 78. France Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 79. France Transdermal Gel, by End User USD Million (2018-2023)
  • Table 80. Italy Transdermal Gel, by Type USD Million (2018-2023)
  • Table 81. Italy Transdermal Gel, by Application USD Million (2018-2023)
  • Table 82. Italy Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 83. Italy Transdermal Gel, by End User USD Million (2018-2023)
  • Table 84. United Kingdom Transdermal Gel, by Type USD Million (2018-2023)
  • Table 85. United Kingdom Transdermal Gel, by Application USD Million (2018-2023)
  • Table 86. United Kingdom Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 87. United Kingdom Transdermal Gel, by End User USD Million (2018-2023)
  • Table 88. Netherlands Transdermal Gel, by Type USD Million (2018-2023)
  • Table 89. Netherlands Transdermal Gel, by Application USD Million (2018-2023)
  • Table 90. Netherlands Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 91. Netherlands Transdermal Gel, by End User USD Million (2018-2023)
  • Table 92. Rest of Europe Transdermal Gel, by Type USD Million (2018-2023)
  • Table 93. Rest of Europe Transdermal Gel, by Application USD Million (2018-2023)
  • Table 94. Rest of Europe Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 95. Rest of Europe Transdermal Gel, by End User USD Million (2018-2023)
  • Table 96. MEA Transdermal Gel, by Country USD Million (2018-2023)
  • Table 97. MEA Transdermal Gel, by Type USD Million (2018-2023)
  • Table 98. MEA Transdermal Gel, by Application USD Million (2018-2023)
  • Table 99. MEA Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 100. MEA Transdermal Gel, by End User USD Million (2018-2023)
  • Table 101. Middle East Transdermal Gel, by Type USD Million (2018-2023)
  • Table 102. Middle East Transdermal Gel, by Application USD Million (2018-2023)
  • Table 103. Middle East Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 104. Middle East Transdermal Gel, by End User USD Million (2018-2023)
  • Table 105. Africa Transdermal Gel, by Type USD Million (2018-2023)
  • Table 106. Africa Transdermal Gel, by Application USD Million (2018-2023)
  • Table 107. Africa Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 108. Africa Transdermal Gel, by End User USD Million (2018-2023)
  • Table 109. North America Transdermal Gel, by Country USD Million (2018-2023)
  • Table 110. North America Transdermal Gel, by Type USD Million (2018-2023)
  • Table 111. North America Transdermal Gel, by Application USD Million (2018-2023)
  • Table 112. North America Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 113. North America Transdermal Gel, by End User USD Million (2018-2023)
  • Table 114. United States Transdermal Gel, by Type USD Million (2018-2023)
  • Table 115. United States Transdermal Gel, by Application USD Million (2018-2023)
  • Table 116. United States Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 117. United States Transdermal Gel, by End User USD Million (2018-2023)
  • Table 118. Canada Transdermal Gel, by Type USD Million (2018-2023)
  • Table 119. Canada Transdermal Gel, by Application USD Million (2018-2023)
  • Table 120. Canada Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 121. Canada Transdermal Gel, by End User USD Million (2018-2023)
  • Table 122. Mexico Transdermal Gel, by Type USD Million (2018-2023)
  • Table 123. Mexico Transdermal Gel, by Application USD Million (2018-2023)
  • Table 124. Mexico Transdermal Gel, by Distribution Channels USD Million (2018-2023)
  • Table 125. Mexico Transdermal Gel, by End User USD Million (2018-2023)
  • Table 126. Transdermal Gel Sales: by Type(K Units)
  • Table 127. Transdermal Gel Sales Ionophoresis , by Region K Units (2018-2023)
  • Table 128. Transdermal Gel Sales Electroporation , by Region K Units (2018-2023)
  • Table 129. Transdermal Gel Sales Sonophoresis , by Region K Units (2018-2023)
  • Table 130. Transdermal Gel Sales: by Application(K Units)
  • Table 131. Transdermal Gel Sales Hospital , by Region K Units (2018-2023)
  • Table 132. Transdermal Gel Sales Clinic , by Region K Units (2018-2023)
  • Table 133. Transdermal Gel Sales Other , by Region K Units (2018-2023)
  • Table 134. Transdermal Gel Sales: by Distribution Channels(K Units)
  • Table 135. Transdermal Gel Sales Ecommerce , by Region K Units (2018-2023)
  • Table 136. Transdermal Gel Sales Medical Stores , by Region K Units (2018-2023)
  • Table 137. Transdermal Gel Sales Hospital Pharmacies , by Region K Units (2018-2023)
  • Table 138. Transdermal Gel Sales: by End User(K Units)
  • Table 139. Transdermal Gel Sales Adults , by Region K Units (2018-2023)
  • Table 140. Transdermal Gel Sales Adolescents , by Region K Units (2018-2023)
  • Table 141. Transdermal Gel Sales Children , by Region K Units (2018-2023)
  • Table 142. South America Transdermal Gel Sales, by Country K Units (2018-2023)
  • Table 143. South America Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 144. South America Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 145. South America Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 146. South America Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 147. Brazil Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 148. Brazil Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 149. Brazil Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 150. Brazil Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 151. Argentina Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 152. Argentina Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 153. Argentina Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 154. Argentina Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 155. Rest of South America Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 156. Rest of South America Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 157. Rest of South America Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 158. Rest of South America Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 159. Asia Pacific Transdermal Gel Sales, by Country K Units (2018-2023)
  • Table 160. Asia Pacific Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 161. Asia Pacific Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 162. Asia Pacific Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 163. Asia Pacific Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 164. China Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 165. China Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 166. China Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 167. China Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 168. Japan Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 169. Japan Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 170. Japan Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 171. Japan Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 172. India Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 173. India Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 174. India Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 175. India Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 176. South Korea Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 177. South Korea Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 178. South Korea Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 179. South Korea Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 180. Taiwan Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 181. Taiwan Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 182. Taiwan Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 183. Taiwan Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 184. Australia Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 185. Australia Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 186. Australia Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 187. Australia Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 188. Rest of Asia-Pacific Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 189. Rest of Asia-Pacific Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 190. Rest of Asia-Pacific Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 191. Rest of Asia-Pacific Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 192. Europe Transdermal Gel Sales, by Country K Units (2018-2023)
  • Table 193. Europe Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 194. Europe Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 195. Europe Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 196. Europe Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 197. Germany Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 198. Germany Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 199. Germany Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 200. Germany Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 201. France Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 202. France Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 203. France Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 204. France Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 205. Italy Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 206. Italy Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 207. Italy Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 208. Italy Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 209. United Kingdom Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 210. United Kingdom Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 211. United Kingdom Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 212. United Kingdom Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 213. Netherlands Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 214. Netherlands Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 215. Netherlands Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 216. Netherlands Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 217. Rest of Europe Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 218. Rest of Europe Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 219. Rest of Europe Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 220. Rest of Europe Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 221. MEA Transdermal Gel Sales, by Country K Units (2018-2023)
  • Table 222. MEA Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 223. MEA Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 224. MEA Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 225. MEA Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 226. Middle East Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 227. Middle East Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 228. Middle East Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 229. Middle East Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 230. Africa Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 231. Africa Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 232. Africa Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 233. Africa Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 234. North America Transdermal Gel Sales, by Country K Units (2018-2023)
  • Table 235. North America Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 236. North America Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 237. North America Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 238. North America Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 239. United States Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 240. United States Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 241. United States Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 242. United States Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 243. Canada Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 244. Canada Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 245. Canada Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 246. Canada Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 247. Mexico Transdermal Gel Sales, by Type K Units (2018-2023)
  • Table 248. Mexico Transdermal Gel Sales, by Application K Units (2018-2023)
  • Table 249. Mexico Transdermal Gel Sales, by Distribution Channels K Units (2018-2023)
  • Table 250. Mexico Transdermal Gel Sales, by End User K Units (2018-2023)
  • Table 251. Transdermal Gel: by Type(USD/Units)
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Transdermal Gel: by Type(USD Million)
  • Table 260. Transdermal Gel Ionophoresis , by Region USD Million (2025-2030)
  • Table 261. Transdermal Gel Electroporation , by Region USD Million (2025-2030)
  • Table 262. Transdermal Gel Sonophoresis , by Region USD Million (2025-2030)
  • Table 263. Transdermal Gel: by Application(USD Million)
  • Table 264. Transdermal Gel Hospital , by Region USD Million (2025-2030)
  • Table 265. Transdermal Gel Clinic , by Region USD Million (2025-2030)
  • Table 266. Transdermal Gel Other , by Region USD Million (2025-2030)
  • Table 267. Transdermal Gel: by Distribution Channels(USD Million)
  • Table 268. Transdermal Gel Ecommerce , by Region USD Million (2025-2030)
  • Table 269. Transdermal Gel Medical Stores , by Region USD Million (2025-2030)
  • Table 270. Transdermal Gel Hospital Pharmacies , by Region USD Million (2025-2030)
  • Table 271. Transdermal Gel: by End User(USD Million)
  • Table 272. Transdermal Gel Adults , by Region USD Million (2025-2030)
  • Table 273. Transdermal Gel Adolescents , by Region USD Million (2025-2030)
  • Table 274. Transdermal Gel Children , by Region USD Million (2025-2030)
  • Table 275. South America Transdermal Gel, by Country USD Million (2025-2030)
  • Table 276. South America Transdermal Gel, by Type USD Million (2025-2030)
  • Table 277. South America Transdermal Gel, by Application USD Million (2025-2030)
  • Table 278. South America Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 279. South America Transdermal Gel, by End User USD Million (2025-2030)
  • Table 280. Brazil Transdermal Gel, by Type USD Million (2025-2030)
  • Table 281. Brazil Transdermal Gel, by Application USD Million (2025-2030)
  • Table 282. Brazil Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 283. Brazil Transdermal Gel, by End User USD Million (2025-2030)
  • Table 284. Argentina Transdermal Gel, by Type USD Million (2025-2030)
  • Table 285. Argentina Transdermal Gel, by Application USD Million (2025-2030)
  • Table 286. Argentina Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 287. Argentina Transdermal Gel, by End User USD Million (2025-2030)
  • Table 288. Rest of South America Transdermal Gel, by Type USD Million (2025-2030)
  • Table 289. Rest of South America Transdermal Gel, by Application USD Million (2025-2030)
  • Table 290. Rest of South America Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 291. Rest of South America Transdermal Gel, by End User USD Million (2025-2030)
  • Table 292. Asia Pacific Transdermal Gel, by Country USD Million (2025-2030)
  • Table 293. Asia Pacific Transdermal Gel, by Type USD Million (2025-2030)
  • Table 294. Asia Pacific Transdermal Gel, by Application USD Million (2025-2030)
  • Table 295. Asia Pacific Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 296. Asia Pacific Transdermal Gel, by End User USD Million (2025-2030)
  • Table 297. China Transdermal Gel, by Type USD Million (2025-2030)
  • Table 298. China Transdermal Gel, by Application USD Million (2025-2030)
  • Table 299. China Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 300. China Transdermal Gel, by End User USD Million (2025-2030)
  • Table 301. Japan Transdermal Gel, by Type USD Million (2025-2030)
  • Table 302. Japan Transdermal Gel, by Application USD Million (2025-2030)
  • Table 303. Japan Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 304. Japan Transdermal Gel, by End User USD Million (2025-2030)
  • Table 305. India Transdermal Gel, by Type USD Million (2025-2030)
  • Table 306. India Transdermal Gel, by Application USD Million (2025-2030)
  • Table 307. India Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 308. India Transdermal Gel, by End User USD Million (2025-2030)
  • Table 309. South Korea Transdermal Gel, by Type USD Million (2025-2030)
  • Table 310. South Korea Transdermal Gel, by Application USD Million (2025-2030)
  • Table 311. South Korea Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 312. South Korea Transdermal Gel, by End User USD Million (2025-2030)
  • Table 313. Taiwan Transdermal Gel, by Type USD Million (2025-2030)
  • Table 314. Taiwan Transdermal Gel, by Application USD Million (2025-2030)
  • Table 315. Taiwan Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 316. Taiwan Transdermal Gel, by End User USD Million (2025-2030)
  • Table 317. Australia Transdermal Gel, by Type USD Million (2025-2030)
  • Table 318. Australia Transdermal Gel, by Application USD Million (2025-2030)
  • Table 319. Australia Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 320. Australia Transdermal Gel, by End User USD Million (2025-2030)
  • Table 321. Rest of Asia-Pacific Transdermal Gel, by Type USD Million (2025-2030)
  • Table 322. Rest of Asia-Pacific Transdermal Gel, by Application USD Million (2025-2030)
  • Table 323. Rest of Asia-Pacific Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 324. Rest of Asia-Pacific Transdermal Gel, by End User USD Million (2025-2030)
  • Table 325. Europe Transdermal Gel, by Country USD Million (2025-2030)
  • Table 326. Europe Transdermal Gel, by Type USD Million (2025-2030)
  • Table 327. Europe Transdermal Gel, by Application USD Million (2025-2030)
  • Table 328. Europe Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 329. Europe Transdermal Gel, by End User USD Million (2025-2030)
  • Table 330. Germany Transdermal Gel, by Type USD Million (2025-2030)
  • Table 331. Germany Transdermal Gel, by Application USD Million (2025-2030)
  • Table 332. Germany Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 333. Germany Transdermal Gel, by End User USD Million (2025-2030)
  • Table 334. France Transdermal Gel, by Type USD Million (2025-2030)
  • Table 335. France Transdermal Gel, by Application USD Million (2025-2030)
  • Table 336. France Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 337. France Transdermal Gel, by End User USD Million (2025-2030)
  • Table 338. Italy Transdermal Gel, by Type USD Million (2025-2030)
  • Table 339. Italy Transdermal Gel, by Application USD Million (2025-2030)
  • Table 340. Italy Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 341. Italy Transdermal Gel, by End User USD Million (2025-2030)
  • Table 342. United Kingdom Transdermal Gel, by Type USD Million (2025-2030)
  • Table 343. United Kingdom Transdermal Gel, by Application USD Million (2025-2030)
  • Table 344. United Kingdom Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 345. United Kingdom Transdermal Gel, by End User USD Million (2025-2030)
  • Table 346. Netherlands Transdermal Gel, by Type USD Million (2025-2030)
  • Table 347. Netherlands Transdermal Gel, by Application USD Million (2025-2030)
  • Table 348. Netherlands Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 349. Netherlands Transdermal Gel, by End User USD Million (2025-2030)
  • Table 350. Rest of Europe Transdermal Gel, by Type USD Million (2025-2030)
  • Table 351. Rest of Europe Transdermal Gel, by Application USD Million (2025-2030)
  • Table 352. Rest of Europe Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 353. Rest of Europe Transdermal Gel, by End User USD Million (2025-2030)
  • Table 354. MEA Transdermal Gel, by Country USD Million (2025-2030)
  • Table 355. MEA Transdermal Gel, by Type USD Million (2025-2030)
  • Table 356. MEA Transdermal Gel, by Application USD Million (2025-2030)
  • Table 357. MEA Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 358. MEA Transdermal Gel, by End User USD Million (2025-2030)
  • Table 359. Middle East Transdermal Gel, by Type USD Million (2025-2030)
  • Table 360. Middle East Transdermal Gel, by Application USD Million (2025-2030)
  • Table 361. Middle East Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 362. Middle East Transdermal Gel, by End User USD Million (2025-2030)
  • Table 363. Africa Transdermal Gel, by Type USD Million (2025-2030)
  • Table 364. Africa Transdermal Gel, by Application USD Million (2025-2030)
  • Table 365. Africa Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 366. Africa Transdermal Gel, by End User USD Million (2025-2030)
  • Table 367. North America Transdermal Gel, by Country USD Million (2025-2030)
  • Table 368. North America Transdermal Gel, by Type USD Million (2025-2030)
  • Table 369. North America Transdermal Gel, by Application USD Million (2025-2030)
  • Table 370. North America Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 371. North America Transdermal Gel, by End User USD Million (2025-2030)
  • Table 372. United States Transdermal Gel, by Type USD Million (2025-2030)
  • Table 373. United States Transdermal Gel, by Application USD Million (2025-2030)
  • Table 374. United States Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 375. United States Transdermal Gel, by End User USD Million (2025-2030)
  • Table 376. Canada Transdermal Gel, by Type USD Million (2025-2030)
  • Table 377. Canada Transdermal Gel, by Application USD Million (2025-2030)
  • Table 378. Canada Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 379. Canada Transdermal Gel, by End User USD Million (2025-2030)
  • Table 380. Mexico Transdermal Gel, by Type USD Million (2025-2030)
  • Table 381. Mexico Transdermal Gel, by Application USD Million (2025-2030)
  • Table 382. Mexico Transdermal Gel, by Distribution Channels USD Million (2025-2030)
  • Table 383. Mexico Transdermal Gel, by End User USD Million (2025-2030)
  • Table 384. Transdermal Gel Sales: by Type(K Units)
  • Table 385. Transdermal Gel Sales Ionophoresis , by Region K Units (2025-2030)
  • Table 386. Transdermal Gel Sales Electroporation , by Region K Units (2025-2030)
  • Table 387. Transdermal Gel Sales Sonophoresis , by Region K Units (2025-2030)
  • Table 388. Transdermal Gel Sales: by Application(K Units)
  • Table 389. Transdermal Gel Sales Hospital , by Region K Units (2025-2030)
  • Table 390. Transdermal Gel Sales Clinic , by Region K Units (2025-2030)
  • Table 391. Transdermal Gel Sales Other , by Region K Units (2025-2030)
  • Table 392. Transdermal Gel Sales: by Distribution Channels(K Units)
  • Table 393. Transdermal Gel Sales Ecommerce , by Region K Units (2025-2030)
  • Table 394. Transdermal Gel Sales Medical Stores , by Region K Units (2025-2030)
  • Table 395. Transdermal Gel Sales Hospital Pharmacies , by Region K Units (2025-2030)
  • Table 396. Transdermal Gel Sales: by End User(K Units)
  • Table 397. Transdermal Gel Sales Adults , by Region K Units (2025-2030)
  • Table 398. Transdermal Gel Sales Adolescents , by Region K Units (2025-2030)
  • Table 399. Transdermal Gel Sales Children , by Region K Units (2025-2030)
  • Table 400. South America Transdermal Gel Sales, by Country K Units (2025-2030)
  • Table 401. South America Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 402. South America Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 403. South America Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 404. South America Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 405. Brazil Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 406. Brazil Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 407. Brazil Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 408. Brazil Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 409. Argentina Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 410. Argentina Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 411. Argentina Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 412. Argentina Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 413. Rest of South America Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 414. Rest of South America Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 415. Rest of South America Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 416. Rest of South America Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 417. Asia Pacific Transdermal Gel Sales, by Country K Units (2025-2030)
  • Table 418. Asia Pacific Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 419. Asia Pacific Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 420. Asia Pacific Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 421. Asia Pacific Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 422. China Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 423. China Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 424. China Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 425. China Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 426. Japan Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 427. Japan Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 428. Japan Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 429. Japan Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 430. India Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 431. India Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 432. India Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 433. India Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 434. South Korea Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 435. South Korea Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 436. South Korea Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 437. South Korea Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 438. Taiwan Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 439. Taiwan Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 440. Taiwan Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 441. Taiwan Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 442. Australia Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 443. Australia Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 444. Australia Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 445. Australia Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 446. Rest of Asia-Pacific Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 447. Rest of Asia-Pacific Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 448. Rest of Asia-Pacific Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 449. Rest of Asia-Pacific Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 450. Europe Transdermal Gel Sales, by Country K Units (2025-2030)
  • Table 451. Europe Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 452. Europe Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 453. Europe Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 454. Europe Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 455. Germany Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 456. Germany Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 457. Germany Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 458. Germany Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 459. France Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 460. France Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 461. France Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 462. France Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 463. Italy Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 464. Italy Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 465. Italy Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 466. Italy Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 467. United Kingdom Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 468. United Kingdom Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 469. United Kingdom Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 470. United Kingdom Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 471. Netherlands Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 472. Netherlands Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 473. Netherlands Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 474. Netherlands Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 475. Rest of Europe Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 476. Rest of Europe Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 477. Rest of Europe Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 478. Rest of Europe Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 479. MEA Transdermal Gel Sales, by Country K Units (2025-2030)
  • Table 480. MEA Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 481. MEA Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 482. MEA Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 483. MEA Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 484. Middle East Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 485. Middle East Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 486. Middle East Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 487. Middle East Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 488. Africa Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 489. Africa Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 490. Africa Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 491. Africa Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 492. North America Transdermal Gel Sales, by Country K Units (2025-2030)
  • Table 493. North America Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 494. North America Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 495. North America Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 496. North America Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 497. United States Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 498. United States Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 499. United States Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 500. United States Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 501. Canada Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 502. Canada Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 503. Canada Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 504. Canada Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 505. Mexico Transdermal Gel Sales, by Type K Units (2025-2030)
  • Table 506. Mexico Transdermal Gel Sales, by Application K Units (2025-2030)
  • Table 507. Mexico Transdermal Gel Sales, by Distribution Channels K Units (2025-2030)
  • Table 508. Mexico Transdermal Gel Sales, by End User K Units (2025-2030)
  • Table 509. Transdermal Gel: by Type(USD/Units)
  • Table 510. Research Programs/Design for This Report
  • Table 511. Key Data Information from Secondary Sources
  • Table 512. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Transdermal Gel: by Type USD Million (2018-2023)
  • Figure 5. Global Transdermal Gel: by Application USD Million (2018-2023)
  • Figure 6. Global Transdermal Gel: by Distribution Channels USD Million (2018-2023)
  • Figure 7. Global Transdermal Gel: by End User USD Million (2018-2023)
  • Figure 8. South America Transdermal Gel Share (%), by Country
  • Figure 9. Asia Pacific Transdermal Gel Share (%), by Country
  • Figure 10. Europe Transdermal Gel Share (%), by Country
  • Figure 11. MEA Transdermal Gel Share (%), by Country
  • Figure 12. North America Transdermal Gel Share (%), by Country
  • Figure 13. Global Transdermal Gel: by Type K Units (2018-2023)
  • Figure 14. Global Transdermal Gel: by Application K Units (2018-2023)
  • Figure 15. Global Transdermal Gel: by Distribution Channels K Units (2018-2023)
  • Figure 16. Global Transdermal Gel: by End User K Units (2018-2023)
  • Figure 17. South America Transdermal Gel Share (%), by Country
  • Figure 18. Asia Pacific Transdermal Gel Share (%), by Country
  • Figure 19. Europe Transdermal Gel Share (%), by Country
  • Figure 20. MEA Transdermal Gel Share (%), by Country
  • Figure 21. North America Transdermal Gel Share (%), by Country
  • Figure 22. Global Transdermal Gel: by Type USD/Units (2018-2023)
  • Figure 23. Global Transdermal Gel share by Players 2023 (%)
  • Figure 24. Global Transdermal Gel share by Players (Top 3) 2023(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. 3M Company (United States) Revenue, Net Income and Gross profit
  • Figure 27. 3M Company (United States) Revenue: by Geography 2023
  • Figure 28. Novartis International AG (Germany) Revenue, Net Income and Gross profit
  • Figure 29. Novartis International AG (Germany) Revenue: by Geography 2023
  • Figure 30. Boehringer Ingelheim International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Boehringer Ingelheim International GmbH (Germany) Revenue: by Geography 2023
  • Figure 32. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Mylan N.V (United States) Revenue, Net Income and Gross profit
  • Figure 35. Mylan N.V (United States) Revenue: by Geography 2023
  • Figure 36. Mary's Medicinal (United States) Revenue, Net Income and Gross profit
  • Figure 37. Mary's Medicinal (United States) Revenue: by Geography 2023
  • Figure 38. Zynerba Pharmaceuticals, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Zynerba Pharmaceuticals, Inc. (United States) Revenue: by Geography 2023
  • Figure 40. Global Transdermal Gel: by Type USD Million (2025-2030)
  • Figure 41. Global Transdermal Gel: by Application USD Million (2025-2030)
  • Figure 42. Global Transdermal Gel: by Distribution Channels USD Million (2025-2030)
  • Figure 43. Global Transdermal Gel: by End User USD Million (2025-2030)
  • Figure 44. South America Transdermal Gel Share (%), by Country
  • Figure 45. Asia Pacific Transdermal Gel Share (%), by Country
  • Figure 46. Europe Transdermal Gel Share (%), by Country
  • Figure 47. MEA Transdermal Gel Share (%), by Country
  • Figure 48. North America Transdermal Gel Share (%), by Country
  • Figure 49. Global Transdermal Gel: by Type K Units (2025-2030)
  • Figure 50. Global Transdermal Gel: by Application K Units (2025-2030)
  • Figure 51. Global Transdermal Gel: by Distribution Channels K Units (2025-2030)
  • Figure 52. Global Transdermal Gel: by End User K Units (2025-2030)
  • Figure 53. South America Transdermal Gel Share (%), by Country
  • Figure 54. Asia Pacific Transdermal Gel Share (%), by Country
  • Figure 55. Europe Transdermal Gel Share (%), by Country
  • Figure 56. MEA Transdermal Gel Share (%), by Country
  • Figure 57. North America Transdermal Gel Share (%), by Country
  • Figure 58. Global Transdermal Gel: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • 3M Company (United States)
  • Novartis International AG (Germany)
  • Boehringer Ingelheim International GmbH (Germany)
  • Merck & Co., Inc. (United States)
  • Mylan N.V (United States)
  • Mary's Medicinal (United States)
  • Zynerba Pharmaceuticals, Inc. (United States)
Additional players considered in the study are as follows:
Tapemark (United States) , LTS Lohmann Therapie-Systeme AG (Germany)
Select User Access Type

Key Highlights of Report


Apr 2024 192 Pages 63 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Transdermal Gel Market Quantitative research analysis
Global Transdermal Gel Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Transdermal Gel Market are by type [Ionophoresis, Electroporation and Sonophoresis], by end use application [Hospital, Clinic and Other].
The Transdermal Gel Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Skin Diseases in People Across the World
  • Demand for Minimally Invasive and Painless Approach for Treatment

Know More About Global Transdermal Gel Market Report?

Have a Query? Click Here

Other Related Reports

Dialysis Water Treatment Comprehensive Study by Type (Single-Stage Hemodialysis Water Equipment, Two-Stage Hemodialysis Water Equipment, Others), Application (In-center Dialysis, Hospitals, Independe...
$ 3450
Relationship DNA Tests Comprehensive Study by Type (Mitochondrial DNA Test, Y-Chromosome Test, Genetic Reconstruction Test, Maternity DNA Test, Others), Application (Direct to consumer, Legal service...
$ 3400
Fill Finish Manufacturing Comprehensive Study by Type (Consumables (Prefilled Syringe, Vials, Cartridges), Instruments (Systems, Machine Type)), Application (Contract Manufacturing Organization, Biop...
$ 3750
Specimen Retrieval Comprehensive Study by Type (Detachable Retrieval Bag, Non-Detachable Retrieval Bag, Retrieval Bag With Memory Wire, Others), Application (Gastrointestinal Surgery, Gynecology Surg...
$ 3650
Trivalent Flu Vaccine Comprehensive Study by Application (Hospital, Clinic, Public Health Agency, Other), Distribution Channel (Pharmacies, Grocery Stores, Health Food Shops, Internet Sales, Mail Ord...
$ 3450
Pediatric Antibiotics Comprehensive Study by Type (Amoxicillin, Amoxicillin Clavulanate, Clindamycin HCl, Cephalexin, Penicillin V Potassium), Application (Adults, Geriatric, Children (Greater Than 7...
$ 3750